| 摘要 |
<p>The invention is concerned with a new class of rifamycins, namely, the 25-desacetylrifamycins, and with a process for their preparation. The new compounds display antibacterial activity quite similar to that shown by the parent 25-acetylrifamycins, and are characterized by a higher solubility and a lower toxicity than the parent substances.</p> |
